TCL Archive Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase December 31, 2010
TCL Archive In Brief: House, Senate Pass Rescision Bills; NCI Compromise Figure Probably About $10 Million Cut For FY 1981 May 29, 1981